Our core expertise lies in the analysis and interpretation of whole genome and whole exome data. By identifying the underlying genetic cause of disorders, we support you in determining a diagnosis for your patient.
Arcensus is accredited under ISO 15189:2022 by A2LA, an internationally recognized accreditation body. This accreditation recognizes our adherence to international quality standards in advanced genetic testing through Whole Genome Sequencing, Whole Exome Sequencing and comprehensive clinical reporting from raw sequence data.
The Information Security Management System at Arcensus is ISO 27001:2022 certified, which demonstrates that all our internal and external information managed systems and workflows related to testing and patient data, adhere to global standards for data safety and security.
To further underscore our commitment to deliver accurate and reliable results to patients, CAP accreditation is scheduled for July 2024.
Our core expertise lies in the analysis and interpretation of whole genome and whole exome data. By identifying the underlying genetic cause of disorders, we support you in determining a diagnosis for your patient.
Arcensus is accredited under ISO 15189:2022 by A2LA, an internationally recognized accreditation body. This accreditation recognizes our adherence to international quality standards in advanced genetic testing through Whole Genome Sequencing, Whole Exome Sequencing and comprehensive clinical reporting from raw sequence data.
The Information Security Management System at Arcensus is ISO 27001:2022 certified, which demonstrates that all our internal and external information managed systems and workflows related to testing and patient data, adhere to global standards for data safety and security.
To further underscore our commitment to deliver accurate and reliable results to patients, CAP accreditation is scheduled for July 2024.
Genetic information represents a profoundly personal and sensitive aspect of your patients’ health. Consequently, data privacy and security are foundational to our operations. We guarantee the highest level of confidentiality and security in handling all patient and genetic data.
Our dedication to compliance with data security and privacy regulations is reflected in our ISO 27001:2022 certification. The digital data protection seal from HeyData confirms our commitment to protecting personal data and complying with data protection regulations based on GDPR.
We implement robust encryption measures to safeguard all sensitive genetic data during storage and transmission. By enforcing strict access controls and multifactor authentication protocols we ensure that sensitive information remains protected from unauthorized access.
We conduct routine security audits and assessments to identify and address potential vulnerabilities in the system. We test the integrity of data security measures regularly, including penetration testing, carry out vulnerability assessments and security risk evaluations to proactively identify and mitigate potential security threats.
We adhere to stringent data protection regulations and industry standards, such as GDPR (General Data Protection Regulation), and HIPAA (Health Insurance Portability and Accountability Act) and the German data privacy laws to ensure the highest levels of confidentiality and integrity.
We operate in diverse countries, striving to collaborate and to enhance healthcare diagnostics worldwide. Contact us today to tell us about your needs or to exchange ideas. We look forward to hearing from you.